Erector Spinae Plane Block Versus Transversus Abdominis Plane Block in Abdominoplasty Surgery

Not Applicable

• Conditions: Abdominoplasty
• Interventions: Procedure: Control group; Procedure: Erector spinea plane block group; Procedure: Transversus abdominis plane block

• Registration Number: NCT03940885
• Lead Sponsor: Mansoura University

Brief Summary

Abdominoplasty is one of the most popular body-contouring procedures. Patients that undergo body-contouring abdominoplasty usually have important analgesic requirements. Given the substantial incision and soft-tissue undermining associated with this procedure, postoperative pain is a concern for patients and surgeons. Previous studies have typically incorporated multiple nerve blocks to improve analgesia after abdominoplasty. Different anesthetic techniques have been developed to overcome this problem such as Epidural anesthesia, Transversus abdominis plane block either open technique or ultrasound-guided, Paravertebral block and Erector Spinea plane block. Improving postoperative pain control in this kind of surgery leads to earlier mobilization, shortened hospital stay, reduced hospital costs, and increased patient satisfaction.

The ultrasound-guided erector spinae plane (ESP) block is a recent block described for various surgeries for postoperative analgesia. It is reported that it have an analgesic effect on somatic and visceral pain by affecting the ventral rami and rami communicantes that include sympathetic nerve fibres, as LA spreads through the paravertebral space. When performed bilaterally it has been reported to be as effective as thoracic epidural analgesia.

The transversus abdominis plane (TAP) block is a technique of locoregional anesthesia that blocks the sensorial afferent nerves localized between the transversus abdominis muscle and the internal oblique muscle.

In this study, the analgesic efficacy and duration of ultrasound (US) guided Erector spinea plane block and Transversus abdominis plane block when Lidocaine HCL is added as an adjuvant to bupivacaine will be compared.

Detailed Description

Sample size was calculated using Power Analysis and Sample Size software program (PASS) version 15.0.5 for windows (2017) using previous results with the mean opioid consumption in the first postoperative day as the primary outcome. Effect size of 0.5 (medium effect size) was calculated using the difference between the mean opioid consumption in TAB group (140 mg) and that in ESPB group (124.6 mg) with an estimated standard deviation of 30 in both groups. This study will add a control group in which only intravenous analgesics will be used; hence the aforementioned effect size was used for sample size calculation using a one-way ANOVA test. Sample sizes of 18 patients in each group are needed to achieve 90% power (1-β) to detect differences among the means using an F test with a 0.05 significance level (α). The size of the variation in the means is represented by the effect size f = σm / σ, which is 0.5. A 20% drop out is expected so the drop-out inflated sample size will be 23 patients in each group.

Basic Information
|
Recruitment & Eligibility
|
Study & Design
|
Trial Locations

Study Timeline

• Study Start: 2019-04-01
• Study First Submitted: 2019-05-06
• Study First Submitted QC: 2019-05-06
• Study First Posted: 2019-05-07
• Status Verified: 2020-09
• Last Update Submitted: 2020-09-24
• Last Update Posted: 2020-09-25
• Primary Completion: 2021-04
• Study Completion: 2021-06

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 69

Inclusion Criteria

• American society of anesthesiologist grade I-II

Read More

Exclusion Criteria

• Patient refusal.
• Local skin infection and sepsis at the site of the block.
• Allergy to local anesthetic used.
• Hematological diseases
• Bleeding disease.
• Coagulation abnormality.
• Psychiatric disorders.

Read More

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Control group	Control group	standard general anesthesia
Erector spinea plane block group	Erector spinea plane block group	this group is planned for ultrasound-guided Transversus abdominis plane block
Transversus abdominis plane block	Transversus abdominis plane block	this group is planned for ultrasound-guided Transversus abdominis plane block

Primary Outcome Measures

Name	Time	Method
Total opioid consumption	For 24 hours after performing block	cumulative consumption of rescue opioids during the first postoperative day

Secondary Outcome Measures

Name	Time	Method
Cortisol level	For one hour after performing block	Cortisol level will be assayed in the serum
Nausea and vomiting	For 24 hour after surgery	0: No nausea, 1: mild nausea, 2: moderate nausea, 3: severe nausea or vomiting
Duration of analgesia	for 24 hours after performing block	the first time patient requests analgesia postoperatively
Heart rate	For 24 hours after surgery	Changes in heart rate
Peripheral oxygen saturation	For 24 hours after surgery	Changes in peripheral oxygen saturation as measured with pulse oximetry
Postoperative visual analogue score	for 24 hours after performing block	postoperative visual analogue score (VAS)which will be used to determine the postoperative pain levels in patients. ( 0 representing no pain and 10 is the worst imaginable pain) will be assessed at 2h, 4h,6h,12h,18h and 24h postoperative. Diclofenac75 mg IV and paracetamol 500 mg will be given to all patients in the three groups every 12 hours. If VAS is \> 4 patient will receive pethidine 25 mg IV
Mean arterial blood pressure	For 24 hours after surgery	Changes in mean arterial blood pressure

Trial Locations

Locations (1)

Hanaa M Elbendary; 🇪🇬 Mansourah, DK, Egypt